Jenna Hebert, PhD, Investment Director, Venture, RA Capital Management

Jenna Hebert is an Investment Director on the Venture Team at RA Capital Management, a multi-stage investment manager dedicated to company formation and evidence-based investing in healthcare and life science companies. Jenna focuses on identifying and diligencing opportunities for early-stage investments and advises RA’s portfolio companies. She currently serves as a board observer for Hemab, Alchemab Therapeutics, and Typewriter Therapeutics. Prior to RA, Jenna was an Analyst and Medical Writer at Costello Medical Consulting. Jenna has a B.A. in Neuroscience from University of Pennsylvania and a PhD in Neuroscience from the University of Oxford.